These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 6382440

  • 41. Sex differences in vasoactive intestinal peptide (VIP) concentrations in the anterior pituitary and hypothalamus of rats.
    Riskind PN, Allen JM, Gabriel SM, Koenig JI, Audet-Arnold J.
    Neurosci Lett; 1989 Oct 23; 105(1-2):215-20. PubMed ID: 2485881
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Specificity of receptors to vasoactive intestinal peptide in guinea pig brain.
    Robberecht P, König W, Deschodt-Lanckman M, De Neef P, Christophe J.
    Life Sci; 1979 Sep 03; 25(10):879-84. PubMed ID: 226824
    [No Abstract] [Full Text] [Related]

  • 45. Distribution of VIP neurons in the peripheral and central nervous system.
    Schutzberg M, Hokfelt T, Lundberg JM, Fuxe K, Mutt V, Said S.
    Endocrinol Jpn; 1980 Dec 03; 27 Suppl 1():23-30. PubMed ID: 7014205
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Neuroendocrin basis of the sex behavior].
    Livrea G.
    Arch Sci Biol (Bologna); 1971 Dec 03; 55(2):61-102. PubMed ID: 5005580
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. In vitro autoradiographic localization of vasoactive intestinal peptide (VIP) binding sites in the rat central nervous system.
    Besson J, Dussaillant M, Marie JC, Rostene W, Rosselin G.
    Peptides; 1984 Dec 03; 5(2):339-40. PubMed ID: 6089133
    [Abstract] [Full Text] [Related]

  • 55. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.
    Gozes I, McCune SK, Jacobson L, Warren D, Moody TW, Fridkin M, Brenneman DE.
    J Pharmacol Exp Ther; 1991 Jun 03; 257(3):959-66. PubMed ID: 1646331
    [Abstract] [Full Text] [Related]

  • 56. Ageing and the diurnal expression of mRNAs for vasoactive intestinal peptide and for the VPAC2 and PAC1 receptors in the suprachiasmatic nucleus of male rats.
    Kalló I, Kalamatianos T, Piggins HD, Coen CW.
    J Neuroendocrinol; 2004 Sep 03; 16(9):758-66. PubMed ID: 15344914
    [Abstract] [Full Text] [Related]

  • 57. Vasoactive intestinal polypeptide mRNA and peptide levels are decreased in the anterior pituitary of the human growth hormone-releasing hormone transgenic mouse.
    Hyde JF, Morrison DG, Drake KW, Moore JP, Maley BE.
    J Neuroendocrinol; 1996 Jan 03; 8(1):9-15. PubMed ID: 8932732
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Vasoactive intestinal polypeptide/peptide histidine isoleucine immunoreactive neuron systems in the basal hypothalamus of the rat with special reference to the portal vasculature: an immunohistochemical and in situ hybridization study.
    Ceccatelli S, Fahrenkrug J, Villar MJ, Hökfelt T.
    Neuroscience; 1991 Jan 03; 43(2-3):483-502. PubMed ID: 1922780
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.